Has experience in Nutrition, focusing on Nutrition (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Obesity is a multifactor metabolic disorder with increased prevalence worldwide. Pharmacological treatment has not yet met the safety, efficacy and sustainable maintenance of weight loss. Recent studies demonstrate that the combined activation of GPR40 and GPR120 may contribute to the treatment of Obesity, since POMC neurons (which provide anorexigenic signals in the hypothalamus) express…
Rationale: Obesity is a multifactor metabolic disorder with increased prevalence worldwide. Pharmacological treatment has not yet met the safety, efficacy and sustainable maintenance of weight loss. Recent studies demonstrate that the combined activation of GPR40 and GPR120 may contribute to the treatment of obesity, since POMC neurons (which provide anorexigenic signals in the hypothalam…
Background: Co-sodium-glucose transporter type 2 (SGLT-2) is expressed in kidney and brain, including hypothalamic sites food control. The inhibition of SGLT-2 produces glycosuria and concomitant loss of calories to a decrease in body weight. However, many factors can interfere with weight loss, corresponding to expectations or not. In Brazil, Dapagliflozin is the first SGLT-2 inhibitor a…
| 3 / 3 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID